| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(02)02381-1 |
| P698 | PubMed publication ID | 12427420 |
| P2093 | author name string | Robert P Myers | |
| Dominique Thabut | |||
| Gabriel Thabut | |||
| Michel Fournier | |||
| Hervé Mal | |||
| Brigitte Bernard-Chabert | |||
| Rolana Marrash-Chahla | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis | Q28189245 | ||
| Meta-analysis in clinical research | Q29620885 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry | Q33175305 | ||
| Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | Q33607475 | ||
| Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence | Q33667150 | ||
| Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial. | Q33884490 | ||
| Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial | Q34249941 | ||
| Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism | Q34426628 | ||
| Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials | Q34436046 | ||
| Contemporary pulmonary embolism thrombolysis | Q40564557 | ||
| Strengths and limitations of meta-analysis: Larger studies may be more reliable | Q40874734 | ||
| A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism | Q40906357 | ||
| Cumulative meta-analysis of therapeutic trials for myocardial infarction | Q41112231 | ||
| PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. | Q43604229 | ||
| Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial | Q43784275 | ||
| Pulmonary embolism thromboiysis: A clarion call for international collaboration | Q44916859 | ||
| A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism | Q45021481 | ||
| Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry | Q49163448 | ||
| Methods for combining randomized clinical trials: strengths and limitations | Q52599212 | ||
| Overcoming the limitations of current meta-analysis of randomised controlled trials | Q52900034 | ||
| Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators | Q67273191 | ||
| The clinical course of pulmonary embolism | Q68092509 | ||
| Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary Embolism | Q69335295 | ||
| Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial | Q70261989 | ||
| Cardiovascular risk stratification of pulmonary embolism | Q71771586 | ||
| Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion | Q72211275 | ||
| Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors | Q73336153 | ||
| Pulmonary embolism thrombolysis: broadening the paradigm for its administration | Q73606360 | ||
| Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis | Q73614680 | ||
| Management Strategies and Determinants of Outcome in Acute Major Pulmonary Embolism: Results of a Multicenter Registry | Q73832059 | ||
| Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up | Q74485252 | ||
| Pulmonary embolism | Q74757726 | ||
| Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue | Q77337405 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| thrombolysis | Q1931577 | ||
| P304 | page(s) | 1660-1667 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Thrombolytic therapy of pulmonary embolism: a meta-analysis | |
| P478 | volume | 40 |
| Q37788951 | Acute pulmonary embolism. Part 2: treatment |
| Q42019396 | Aggressive Management of Pulmonary Embolism |
| Q85484261 | Anesthesia for liver transplantation |
| Q35535961 | British Thoracic Society guidelines for the management of suspected acute pulmonary embolism |
| Q43632154 | Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment : randomized controlled parallel group study. |
| Q28238878 | Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Pulmonary Embolism |
| Q59135176 | Efficacy evaluation of reteplase in a novel canine acute pulmonary thromboembolism model developed by minimally invasive surgery and digital subtraction angiography |
| Q38063866 | Forearm Compartment Syndrome following Thrombolytic Therapy for Massive Pulmonary Embolism: A Case Report and Review of Literature |
| Q90388064 | Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management |
| Q34002169 | Impact of catheter fragmentation followed by local intrapulmonary thrombolysis in acute high risk pulmonary embolism as primary therapy |
| Q46801435 | Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin |
| Q38673667 | Intestinal transplantation: The anesthesia perspective |
| Q34427489 | Low-dose tissue plasminogen activator in the treatment of a massive pulmonary thromboembolism in a colon cancer patient treated with bevacizumab: A case report |
| Q38042519 | Management of Massive and Submassive Pulmonary Embolism |
| Q36524815 | Management of massive and nonmassive pulmonary embolism |
| Q54991512 | Management of patients with high-risk pulmonary embolism: a narrative review. |
| Q50294512 | Outcome of Sub-Massive Pulmonary Thromboemboli in Patients Who Received Thrombolytic and or Non-Thrombolytic Therapy. |
| Q37258021 | Outcome of Thrombolysis for Massive Pulmonary Embolism |
| Q53163976 | Peripheral Extracorporeal Membrane Oxygenation: Comprehensive Therapy for High-Risk Massive Pulmonary Embolism |
| Q33639773 | Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure |
| Q79954098 | Pulmonary embolism |
| Q36916723 | Review of acute pulmonary embolism in a general hospital |
| Q35115224 | Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism |
| Q53226048 | Systemic Full Dose, Half Dose, and Catheter Directed Thrombolysis for Pulmonary Embolism. When to Use and How to Choose? |
| Q39042861 | Systemic Thrombolysis for Pulmonary Embolism: A Review |
| Q38219389 | Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. |
| Q36707384 | Tenecteplase to treat pulmonary embolism in the emergency department |
| Q82714955 | The Successful Use of Low-Dose Recombinant Tissue Plasminogen Activator for Treatment of Intracardiac/Pulmonary Thrombosis During Liver Transplantation |
| Q73690470 | Thrombolysis in submassive pulmonary embolism? Yes |
| Q83361479 | Treatment of thromboembolism in IBD: More questions than answers |
| Q35160094 | Upper extremity acute compartment syndrome during tissue plasminogen activator therapy for pulmonary embolism in a morbidly obese patient |
| Q24631121 | Venous Thromboembolic Disease |
| Q35345305 | When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature |
| Q83743922 | [Update in pulmonary thromboembolic disease] |
| Q35217381 | tPA regulates pulmonary vascular activity through NMDA receptors |
Search more.